Utilization of sodium-dependent high affinity choline uptake in vitro as a measure of the activity of cholinergic neurons in vivo.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001693:Biological Transport, Active / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D002474:Cell-Free System; D002540:Cerebral Cortex / Q000378:metabolism; D002794:Choline / Q000378:metabolism*; D003342:Corpus Striatum / Q000378:metabolism; D013759:Dronabinol / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D006624:Hippocampus / Q000378:metabolism; D008297:Male; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D009474:Neurons / Q000378:metabolism*; D010424:Pentobarbital / Q000494:pharmacology; D010433:Pentylenetetrazole / Q000494:pharmacology; D051381:Rats; D012601:Scopolamine / Q000494:pharmacology; D012964:Sodium / Q000378:metabolism; D013574:Synaptosomes / Q000378:metabolism
D009020:Morphine; D001285:Atropine; D013759:Dronabinol; D012964:Sodium; D012601:Scopolamine; D010424:Pentobarbital; D006220:Haloperidol; D002794:Choline; D010433:Pentylenetetrazole